Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kastriotis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Endourology|March 1, 2005
Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complicationsG Alivizatos, N Ferakis, D Mitropoulos, et al.
International Urology and Nephrology|January 1, 1995
Carcinosarcoma of the bladderG Sakkas, I Kastriotis, A Karagiannis, et al.
European Urology|January 1, 1997
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group studyD V Skarlos, G Aravantinos, E Linardou, et al.
Urology|December 31, 1997
Oral estramustine and oral etoposide for hormone-refractory prostate cancerM A Dimopoulos, C Panopoulos, C Bamia, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Endourology|March 1, 2005
Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complicationsG Alivizatos, N Ferakis, D Mitropoulos, et al.
International Urology and Nephrology|January 1, 1995
Carcinosarcoma of the bladderG Sakkas, I Kastriotis, A Karagiannis, et al.
European Urology|January 1, 1997
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group studyD V Skarlos, G Aravantinos, E Linardou, et al.
Urology|December 31, 1997
Oral estramustine and oral etoposide for hormone-refractory prostate cancerM A Dimopoulos, C Panopoulos, C Bamia, et al.
Pageof 1